The stock of Eli Lilly and Company LLY has declined 1.7% already this week, losing almost $14 billion of its market value.

The drugmaker's financial results are also impressive, spearheaded by tirzepatide, a therapy for diabetes and obesity that is ...

Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high ...

You’ve probably heard of the semaglutide brand names Ozempic®, Wegovy, and Rybelsus. You may have even heard about affordable options like compounded semaglutide.

Academic notes while Ozempic might prevent overdoses, weight loss drug may not actually reduce or end substance use ...

The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...

A new study found a link between new popular GIP/GLP-1 receptor agonists and a reduced rate of overdose or intoxication in ...

Not everybody loses the same amount of weight on medications such as Ozempic and Saxenda—treatment indication, dosage, and ...

The plans to use give unemployed overweight people Mounjaro were introduced by Wes Streeting earlier this week.

In Mounjaro it’s tirzepatide. I’d noticed that my weight had been creeping up, and I can’t deny that a passion for French ...

Left untreated, obstructive sleep apnea is linked to daytime sleepiness and an increased risk of anxiety, diabetes, ...

Hims & Hers is revolutionizing healthcare with affordable, convenient telehealth services, leading to a 260% stock increase in the last year. Read more here.